| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/25/2006 | CN1726021A Alpha2delta ligands for the treatment of sexual dysfunction |
| 01/25/2006 | CN1726015A Alpha2delta ligands for different pharmaceutical uses |
| 01/25/2006 | CN1724687A Relativity of proangiotension transferase 2 gene and prinary hypertension |
| 01/25/2006 | CN1724521A New quinazoline hind derivative, medicinal composition containing same and their use |
| 01/25/2006 | CN1724047A Application of medicinal composition contg. red lady-slipper for preparing medicine of anti-aspirin-resistance |
| 01/25/2006 | CN1724046A Application of medicine contg. sealwort for preparing medicine of anti-aspirin-resistance |
| 01/25/2006 | CN1724043A Oral soup for treating heart or brain diseases |
| 01/25/2006 | CN1724035A Application of medicine contg. wilsonii used for anti aspirin resistance |
| 01/25/2006 | CN1724031A Medicine for treating rhomboembolia type angiitis |
| 01/25/2006 | CN1724028A Traditional Chinese medicine for treating bed sore, and its prepn. method |
| 01/25/2006 | CN1724026A Application of medicinal composition for preparing medicine for treating aspirin-resistance |
| 01/25/2006 | CN1724013A Traditional Chinese medicinal prepn. for treating obstruction of qi in the chest |
| 01/25/2006 | CN1724005A Method for extracting volatile oil and liposoluble alkaloid from plumula nelumbini |
| 01/25/2006 | CN1724000A Injection for treating cardiovascular and cerebrovascular diseases, and its prepn. method |
| 01/25/2006 | CN1723998A Compound red-rooted salvia prepn., and its prepn. method |
| 01/25/2006 | CN1723996A Injection for treating candiovascular and cerebrovascular diseases, and its prepn. method |
| 01/25/2006 | CN1723995A Application of an injection for preparing medicine to treat aspirin-resistance |
| 01/25/2006 | CN1723994A Application of prepn. contg. extractive of red-rooted salvia in medicine of anti-aspirin-resistance |
| 01/25/2006 | CN1723993A Application of medicine used in anti-aspirin-resistance medicine |
| 01/25/2006 | CN1723989A Extractive of kudzu, and its prepn. method and use |
| 01/25/2006 | CN1723988A Medicinal composition contg. glucoside of pueravia flower and its application |
| 01/25/2006 | CN1723987A Preparing method of radix puerariae formula |
| 01/25/2006 | CN1723983A Application of medicinal composition contg. Astragalus mongholicus in preparing medicine for treating aspirin-resistance disease |
| 01/25/2006 | CN1723982A Application of medicine for preparing aspirin-resistance medicine |
| 01/25/2006 | CN1723977A Application of medicine contg. storax for preparing medicine of anti-aspirin-resistance |
| 01/25/2006 | CN1723975A Application of medicine contg. safflower for preparing medicine of anti-aspirn-resistance |
| 01/25/2006 | CN1723974A Application of medicine contg. ligusticum wallichii for preparing medicine of anti-aspirn-resistance |
| 01/25/2006 | CN1723972A Compounding medicinal capsule for treating angiitis |
| 01/25/2006 | CN1723971A Effervescent tables for treating thrombus, and its prepn. method |
| 01/25/2006 | CN1723968A Medicinal composition contg. Ligusticum wallichii used in anti-aspirin-resistance medicine |
| 01/25/2006 | CN1723961A Injection contg. extractive of ginkgo leaf and ginseng, and its prodn. art |
| 01/25/2006 | CN1723958A Method for extracting spore oil from exosporium-broken spore of glossy ganoderma |
| 01/25/2006 | CN1723933A Traditional Chinese medicine capsule for treating application, and its prodn. method |
| 01/25/2006 | CN1723913A Method for preparing coenzyme-A sublingual lozenge |
| 01/25/2006 | CN1723912A Medicinal composition contg. ginseng secondary glycosides, prepn. method and application thereof |
| 01/25/2006 | CN1723896A Vinthitine liposome |
| 01/25/2006 | CN1723879A Application of schisanhenol for preparing medicine for treating ischemic brain apoplexy |
| 01/25/2006 | CN1238363C Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 01/25/2006 | CN1238347C Heterocyclic derivatives |
| 01/25/2006 | CN1238342C Novel amlodipine camsylate and method for preparing thereof |
| 01/25/2006 | CN1238330C Salts of asiatic and madecassic acid suitable for preparation of pharmaceutical and cosmetic compositions |
| 01/25/2006 | CN1238058C Implanting device with anti-DNA lgM-DNA compound and preparation method thereof |
| 01/25/2006 | CN1238054C Biotechnological formulation for suppressing and killing helicobacter pylori, its preparation and its uses |
| 01/25/2006 | CN1238046C Traditional Chinese medicine for treating encephalatrophy and cerebral hemiplegia |
| 01/25/2006 | CN1238029C Decoction for treating cardiovascular and cerebrovascular disease |
| 01/25/2006 | CN1238016C Medicine for treating cardiovascular disease |
| 01/25/2006 | CN1238013C Myocarditis treating Chinese medicine preparation |
| 01/25/2006 | CN1238004C Instant granula for invigorating pulse and promoting circulation of cerebral blood |
| 01/25/2006 | CN1238003C Lotion for treating anus disease and production method |
| 01/25/2006 | CN1237982C Cactus primary juice and its preparation method and application |
| 01/25/2006 | CN1237981C Ginkgo leaf oral disintegrating tablet and its preparation method |
| 01/25/2006 | CN1237975C Application of general saponin of gen-seng fruit in the preparation process of myocarditis treating medicine |
| 01/25/2006 | CN1237972C Active component of muskrat fragrant, preparing technique and usage |
| 01/25/2006 | CN1237971C Compound hypotension preparation containing angiotonin converzyme inhibitor, calcium ion antagonist and Estazolam |
| 01/25/2006 | CN1237966C Compound hypotension preparation |
| 01/25/2006 | CN1237960C Preparation method of aspirin microsphere |
| 01/25/2006 | CN1237957C Hypocrellin liposome solid powder preparaton and producing method |
| 01/24/2006 | US6989435 Compounds and methods to inhibit or augment an inflammatory response |
| 01/24/2006 | US6989402 Thyroid receptor ligands and method II |
| 01/24/2006 | US6989393 Ccr5 modulators benzimidazoles or benzotriazoles |
| 01/24/2006 | US6989388 Antitumor agents; anticancer agents; antiischemic agents; antiinflamamtory agents |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | US6989382 Enzyme inhibitors; pyridin-2-yl-amino-ethyl-amino-phenyl derivatives; diabetes, Alzheimer's disease, Parkinson's disease, Huntington's disease, obesity, cardiovascular disease, hypertension, polycystic ovary syndrome, ischemia, brain injury |
| 01/24/2006 | US6989376 Nervous system disorders; administering exogenous uridine compound |
| 01/24/2006 | US6989374 Gene therapy for cardiomyopathy |
| 01/24/2006 | US6989372 medicaments intended to increase the intracellular and/or extracellular level of glutathione (GSH); for example, N-(N-Acetyl-L-cysteinyl)-S-acetylcysteamine; hiv treatment |
| 01/24/2006 | US6989366 Exendins, exendin agonists, and methods for their use |
| 01/24/2006 | US6989364 treatment extends to all stages of progression of cardiac hypertrophy, with or without structural damage of the heart muscle, regardless of the underlying cardiac disorder |
| 01/24/2006 | US6989260 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders |
| 01/24/2006 | US6989165 Synergistic composition for treating hyperilipdemia |
| 01/24/2006 | US6989156 Forming a free- standing powder comprising at least one antimicrobial metal with atomic disorder; and injecting the free-standing powder in therapeutically effective amounts to the tissue which is to be treated |
| 01/24/2006 | CA2433366C Amlodipine free base |
| 01/24/2006 | CA2368431C Melanocortin receptor ligands |
| 01/24/2006 | CA2352392C Eletriptan hydrobromide monohydrate |
| 01/24/2006 | CA2347117C Methods for inhibiting diabetic complications |
| 01/24/2006 | CA2195747C New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 01/24/2006 | CA2151561C Hydrazino and hydroxyamino-14.beta.-hydroxyandrostane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
| 01/19/2006 | WO2006006741A1 Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 01/19/2006 | WO2006006740A1 3-aminobenamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 01/19/2006 | WO2006005667A2 Polypeptide protracting tags comprising a tetrazole moiety |
| 01/19/2006 | WO2006005415A2 Use of l-carnitine and glucose for the treatment of cardiovascular diseases |
| 01/19/2006 | US20060014963 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 01/19/2006 | US20060014953 7-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-2-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4]triazolo[1,5- alpha ]pyrazine, hydrochloride; antidiabetic agent, non-insulin dependent diabetes; synergistic mixture with other active ingredients |
| 01/19/2006 | US20060014839 Combination of angiotensin II receptor blocker and beta-blocker for secondary prevention of myocardial infarction |
| 01/19/2006 | US20060014837 Use of the (1S, 2R) enantiomer of milnacipran for the preparation of a drug |
| 01/19/2006 | US20060014830 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS |
| 01/19/2006 | US20060014803 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 01/19/2006 | US20060014792 Heterocyclo inhibitors of potassium channel function |
| 01/19/2006 | US20060014787 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 01/19/2006 | US20060014781 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 01/19/2006 | US20060014780 Nicotinamide derivatives useful as PDE4 inhibitors |
| 01/19/2006 | US20060014766 Reacting with sodium hydroxide then calcium chloride to form calcium salt derivative; 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors |
| 01/19/2006 | US20060014762 2-Pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydoimidazo[1,2-A]pyrimidin-5(1H)one derivatives |
| 01/19/2006 | US20060014750 Pharmaceutical compositions for the treatment of CNS and other disorders |
| 01/19/2006 | US20060014747 Ortho-substituted anthranilic acid amides and their use as pharmaceutical agents |
| 01/19/2006 | US20060014734 Immediate release pharmaceutical formulation |
| 01/19/2006 | US20060014725 6-(1-benzyl-3-pentyl-1H-indol-2-yl)-1-bromo-2-naphthyl 1H-tetraazol-5-ylmethyl ether; useful in treating stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 01/19/2006 | US20060014718 oversulfation of epiK-N sulfate to obtain an epiK5-amine-O-oversulfate with very high sulfation degree which by subsequent N-sulfation provides new epiK5-N,O-oversulfate-derivatives; free of activity on the coagulation parameters and useful in the cosmetic or pharmaceutical field |
| 01/19/2006 | US20060014693 Peptide inhibiting platelet derived growth factor (PDGF-BB) and fibroblast growth factor (bFGF) activity |
| 01/19/2006 | US20060014679 Drug screening; diabetes, obesity, hyperlipemia, arteriosclerosis, hypertension, cardiovascular disorders |